Other languages Implantica AG

Equities

IMP A SDB

SE0014855029

Delayed Nasdaq Stockholm Other stock markets 05:50:50 02/05/2024 pm IST			5-day change	1st Jan Change
27.75 ^SEK	+1.28%		-4.34%	+15.27%

26/04	Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	CI
27/03	Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	27/03
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	27/03
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process	26/03
Implantica to Deploy GERD Treatment in Spain	19/03
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe	19/03
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.	05/03
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany	15/02
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy	13/02
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin	06/02
Implantica AG (publ.) Adds Another RefluxStop Center in Spain	18/12
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK	21/11
Implantica Wins EU Medical Device Certifications	07/23/07
Implantica AG Receives MDR Certification for RefluxStop?	07/23/07
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/23/24
Implantica AG Further Expands Its Commercial Footprint in Italy	29/23/29
Implantica AG Announces RefluxStop Results Were Presented At the DDW Conference in Chicago	16/23/16
Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12
Implantica AG (OM:IMP A SDB) commences an Equity Buyback Plan, under the authorization approved on May 10, 2022.	06/23/06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Implantica AG

Equities

IMP A SDB

SE0014855029

Other languages

Filters